Five Prime Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FPRX and buy or sell other stocks, ETFs, and their options commission-free!About FPRX
Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150.
CEODavid M. Reese, MD
CEODavid M. Reese, MD
Employees—
Employees—
HeadquartersThousand Oaks, California
HeadquartersThousand Oaks, California
Founded2001
Founded2001
Employees—
Employees—
FPRX Key Statistics
Market cap1.77B
Market cap1.77B
Price-Earnings ratio-14.16
Price-Earnings ratio-14.16
Dividend yield—
Dividend yield—
Average volume1.11M
Average volume1.11M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$38.90
52 Week high$38.90
52 Week low$2.64
52 Week low$2.64
Stock Snapshot
Five Prime Therapeutics(FPRX) stock is priced at $38.00, giving the company a market capitalization of 1.77B. It carries a P/E multiple of -14.16.
During the trading day, Five Prime Therapeutics(FPRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.11M.
Over the past 52 weeks, Five Prime Therapeutics(FPRX) stock has traded between a high of $38.90 and a low of $2.64.
Over the past 52 weeks, Five Prime Therapeutics(FPRX) stock has traded between a high of $38.90 and a low of $2.64.
People also own
Based on the portfolios of people who own FPRX. This list is generated using Robinhood data, and it’s not a recommendation.